2 results match your criteria: "AZ Sint Lucas General Hospital[Affiliation]"
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med
December 2021
Laboratory of Mucosal Immunology, VIB-UGhent Center for Inflammation Research, Ghent University, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Department of Pulmonary Medicine, University Hospital Ghent, Ghent, Belgium. Electronic address:
Article Synopsis
- This study investigated whether blocking the IL-6 or IL-1 pathways could help improve clinical outcomes in hospitalized COVID-19 patients suffering from hypoxic respiratory failure and cytokine release syndrome.
- A randomized, multicenter trial was conducted with 16 hospitals in Belgium, focusing on patients with specific criteria related to COVID-19 symptoms, oxygen levels, and markers of systemic inflammation.
- The trial employed a factorial design to assess the effectiveness of IL-1 blockade with anakinra compared to a control group, exploring its impact on the recovery timeline for severely ill patients.
Sweet's or not: a cutaneous presentation of a severe disease.
Acta Clin Belg
April 2016
b Department of Oncology and Radiotherapy , AZ Sint Lucas General Hospital, Groenebriel 1, 9000 Ghent , Belgium.